Liminatus Pharma, Inc. (LIMN)
Latest LIMN Insider Trades
About Liminatus Pharma, Inc. (LIMN)
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.
- CERRITOS, CA
- 1
- 2025
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Other acquisition / disposition | 2 | 7,822,529 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
LIMN Insider Transactions (Form 4)
22 Form 4 filings on record, the earliest from Jul 6, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Valetudo Therapeutics LLC - 10% Owner | Other | Common Stock, par value $0.0001 per share | 3,448,926 |
Recent LIMN Form 8-K Filings
5LIMN Insider Trading - FAQ
What is the latest insider trade for LIMN?
Liminatus Pharma, Inc. (LIMN) had 2 insider filings in the last 90 days, with the most recent on 2026-07-14. The full record for LIMN runs to 2 Form 4 filings, the earliest from 2026-07-06. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying LIMN stock?
No insider purchases of LIMN were filed in the last 90 days.
How many insiders are selling LIMN stock?
No insider sales of LIMN were filed in the last 90 days.
Where can I see LIMN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks LIMN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow LIMN insider buys?
Create a free InsiderAlpha account and press Watch on this page to add LIMN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
2Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Valetudo Therapeutics LLC view on EDGAR
- - Valetudo Therapeutics LLC view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where LIMN's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track LIMN insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
